Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inga Zerr

Showing results (131-140 of 358) with videos related to

Pageof 36
Sort By:
Journal of Neurology|November 9, 2019
Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt-Jakob disease: a comparative prospective study with 14-3-3Franc Llorens, Anna Villar-Piqué, Peter Hermann, et al.
Stroke|April 1, 2006
Deletion of cellular prion protein results in reduced Akt activation, enhanced postischemic caspase-3 activation, and exacerbation of ischemic brain injuryJens Weise, Raoul Sandau, Sönke Schwarting, et al.
Dementia and Geriatric Cognitive Disorders|January 6, 2017
Cerebrospinal Fluid Biomarker-Based Diagnosis of Sporadic Creutzfeldt-Jakob Disease: A Validation Study for Previously Established CutoffsFranc Llorens, André Karch, Ewa Golanska, et al.
Journal of Molecular Neuroscience : MN|December 25, 2007
ApoE distribution and family history in genetic prion diseases in GermanyAnna Krasnianski, Nicolas von Ahsen, Uta Heinemann, et al.
Frontiers in Aging Neuroscience|August 20, 2014
Subtype and regional-specific neuroinflammation in sporadic creutzfeldt-jakob diseaseFranc Llorens, Irene López-González, Katrin Thüne, et al.
Neurobiology of Aging|January 15, 2011
Genetic prion disease with codon 196 PRNP mutation: clinical and pathological findingsGabi Schelzke, Sabina Eigenbrod, Carlos Romero, et al.
Frontiers in Bioengineering and Biotechnology|December 17, 2020
Optimization of the Real-Time Quaking-Induced Conversion Assay for Prion Disease DiagnosisInga Zerr, Maria Cramm, Susana Margarida da Silva Correia, et al.
Molecular Neurobiology|January 16, 2016
Strain-Specific Altered Regulatory Response of Rab7a and Tau in Creutzfeldt-Jakob Disease and Alzheimer's DiseaseSaima Zafar, Neelam Younas, Susana Correia, et al.
Annals of Clinical and Translational Neurology|July 17, 2018
CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJDNatalia Ermann, Piotr Lewczuk, Matthias Schmitz, et al.
Molecular Neurobiology|June 3, 2017
Cytoskeleton-Associated Risk Modifiers Involved in Early and Rapid Progression of Sporadic Creutzfeldt-Jakob DiseaseSaima Zafar, Neelam Younas, Nadeem Sheikh, et al.
Pageof 36

Showing results (131-140 of 358) with videos related to

Sort By:
Pageof 36
Journal of Neurology|November 9, 2019
Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt-Jakob disease: a comparative prospective study with 14-3-3Franc Llorens, Anna Villar-Piqué, Peter Hermann, et al.
Stroke|April 1, 2006
Deletion of cellular prion protein results in reduced Akt activation, enhanced postischemic caspase-3 activation, and exacerbation of ischemic brain injuryJens Weise, Raoul Sandau, Sönke Schwarting, et al.
Dementia and Geriatric Cognitive Disorders|January 6, 2017
Cerebrospinal Fluid Biomarker-Based Diagnosis of Sporadic Creutzfeldt-Jakob Disease: A Validation Study for Previously Established CutoffsFranc Llorens, André Karch, Ewa Golanska, et al.
Journal of Molecular Neuroscience : MN|December 25, 2007
ApoE distribution and family history in genetic prion diseases in GermanyAnna Krasnianski, Nicolas von Ahsen, Uta Heinemann, et al.
Frontiers in Aging Neuroscience|August 20, 2014
Subtype and regional-specific neuroinflammation in sporadic creutzfeldt-jakob diseaseFranc Llorens, Irene López-González, Katrin Thüne, et al.
Neurobiology of Aging|January 15, 2011
Genetic prion disease with codon 196 PRNP mutation: clinical and pathological findingsGabi Schelzke, Sabina Eigenbrod, Carlos Romero, et al.
Frontiers in Bioengineering and Biotechnology|December 17, 2020
Optimization of the Real-Time Quaking-Induced Conversion Assay for Prion Disease DiagnosisInga Zerr, Maria Cramm, Susana Margarida da Silva Correia, et al.
Molecular Neurobiology|January 16, 2016
Strain-Specific Altered Regulatory Response of Rab7a and Tau in Creutzfeldt-Jakob Disease and Alzheimer's DiseaseSaima Zafar, Neelam Younas, Susana Correia, et al.
Annals of Clinical and Translational Neurology|July 17, 2018
CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJDNatalia Ermann, Piotr Lewczuk, Matthias Schmitz, et al.
Molecular Neurobiology|June 3, 2017
Cytoskeleton-Associated Risk Modifiers Involved in Early and Rapid Progression of Sporadic Creutzfeldt-Jakob DiseaseSaima Zafar, Neelam Younas, Nadeem Sheikh, et al.
Pageof 36